Journal of Liver

Copper Imbalance and Human Health: A Detailed View of Wilson’s Disease

Nathaniel Okafor^* Department of Internal Medicine, Coastal Biomedical University, Port Harcourt, Nigeria
^*Correspondence: Nathaniel Okafor, Department of Internal Medicine, Coastal Biomedical University, Port Harcourt, Nigeria, Email:

Received: 16-May-2026, Manuscript No. JLR-26-31995; Editor assigned: 19-May-2026, Pre QC No. JLR-26-31995; Reviewed: 29-May-2026, QC No. JLR-26-31995; Revised: 05-Jun-2026, Manuscript No. JLR-26-31995; Published: 12-Jun-2026, DOI: 10.35248/2167-0889.26.15.300

Description

Wilson’s disease is a hereditary disorder in which the body is unable to regulate copper properly, leading to its accumulation in vital organs, particularly the liver and brain. Copper is an essential trace element required for various enzymatic processes, including energy production, connective tissue formation, and neurotransmitter synthesis. Under normal conditions, dietary copper is absorbed in the intestine, transported to the liver, incorporated into ceruloplasmin, and excess amounts are excreted into bile. In individuals with Wilson’s disease, this balance is disrupted due to mutations in the Adenosine Triphosphate (ATP) gene, resulting in impaired copper excretion and toxic buildup.

The liver is the first organ affected because it is the central hub for copper processing. Initially, excess copper accumulates silently within hepatocytes, often without noticeable symptoms. Over time, oxidative stress develops as copper catalyzes the formation of free radicals, damaging cellular structures such as membranes, proteins, and Deoxyribo Nucleic Acid (DNA). This damage can lead to inflammation, fibrosis, and eventually cirrhosis if untreated. Some individuals present with acute liver failure, while others experience a more gradual decline in hepatic function.

As copper levels rise beyond the liver’s storage capacity, it spills into the bloodstream and deposits in other tissues, especially the brain. Neurological involvement is a hallmark of advanced disease and may include tremors, difficulty in coordination, muscle stiffness, and speech disturbances. These manifestations arise from copper deposition in regions such as the basal ganglia, which are responsible for motor control. Psychiatric symptoms can also occur, including mood swings, depression, irritability, and cognitive impairment, often complicating diagnosis because they mimic other mental health conditions.

One of the distinctive clinical features of Wilson’s disease is the presence of Kayser-Fleischer rings, which are brownish or greenish deposits of copper in the cornea. These rings can be detected through slit-lamp examination and are particularly common in patients with neurological symptoms. Although not always present in early stages, their identification can strongly support the diagnosis.

Diagnosis of Wilson’s disease requires a combination of clinical evaluation and laboratory testing. Serum ceruloplasmin levels are typically reduced, although this finding alone is not sufficient for confirmation. Measurement of 24-hour urinary copper excretion is a more reliable indicator, as elevated levels reflect the body’s inability to eliminate copper effectively. Liver biopsy may be performed to quantify hepatic copper concentration, providing direct evidence of accumulation. Genetic testing can identify mutations in the Adenosine Triphosphate (ATP) gene, offering definitive confirmation and enabling family screening.

In cases where liver damage has progressed to advanced cirrhosis or acute liver failure, liver transplantation may be necessary. Transplantation not only replaces the damaged organ but also corrects the underlying metabolic defect, as the new liver possesses normal copper-handling. Outcomes after transplantation are generally favourable, with significant improvement in both hepatic and neurological symptoms.

Despite being considered a rare disorder, Wilson’s disease is likely underdiagnosed due to its variable presentation. Symptoms can appear at any age, from childhood to adulthood, and may differ widely among individuals. Some patients primarily exhibit liver-related signs, while others present with neurological or psychiatric features. This variability often leads to delays in diagnosis, emphasizing the need for awareness among healthcare providers.

The pathophysiology of Wilson’s disease highlights the delicate balance required for trace elements in the human body. While copper is indispensable for normal physiological functions, its excess becomes toxic when regulatory mechanisms fail. Advances in molecular genetics and biochemical testing have improved diagnostic accuracy, allowing for earlier intervention and better long-term outcomes.

The study of Wilson’s disease also contributes to a broader understanding of metabolic disorders and liver physiology. It illustrates how genetic mutations can disrupt biochemical pathways, leading to systemic consequences. Continued research may provide new therapeutic options and enhance current management strategies, further improving patient outcomes.